<html>
<head>
<meta http-equiv="Content-Language" content="en-us">
<meta http-equiv="Content-Type" content="text/html; charset=windows-1252">
<title>Gotham Financial Daily</title>
</head>
<body>
<div id="messageBody">
<p align="center"><b><font face="Arial" size="5" color="#000080">Gotham
Financial</font><font lang="0" face="Arial" color="#000080" size="5"> Daily</font></b><font lang="0" face="Arial" color="#000000" size="3"><br>
</font></p>
<p align="center"><font lang="0" face="Arial" color="#000000" size="3"><b>
BioElectronics Corp.</b></font></p>
<p align="center"><b><font face="Arial">(OTC PINK SHEETS: BIEL)</font></b><font lang="0" face="Arial" color="#000000" size="3"><br>
</font><font lang="0" face="Arial" color="#000000" size="2"> </font></p>
<p align="left"><b><font face="Arial" size="2" color="#800000">**MEGA
TRADING ALERT**</font></b></p>
<p align="left"><font lang="0" face="Arial" color="#000000" size="2"><b>
SPECIAL-ALERT-</b></font><b><font lang="0" face="Arial" size="2" color="#800000">BIEL.PK</font><font lang="0" face="Arial" color="#000000" size="3"><br>
</font><font lang="0" face="Arial" color="#000000" size="2">Check out the
gains from recent </font>
<font lang="0" face="Arial" color="#800000" size="2">strong-buy</font><font lang="0" face="Arial" color="#000000" size="2">
recommendations...</font><font lang="0" face="Arial" color="#000000" size="3"><br>
<br>
</font><font lang="0" face="Arial" color="#000000" size="2">December?HTSC at
.70 High 3.25....</font><font lang="0" face="Arial" color="#008040" size="2">410%
Gain! </font><font lang="0" face="Arial" color="#000000" size="2"><br>
January?...QLHC at 90 High 3.50....</font><font lang="0" face="Arial" color="#008040" size="2">389%
Gain! </font><font lang="0" face="Arial" color="#000000" size="2"><br>
April ??.....IPYS at .30 High 1.10.....</font><font lang="0" face="Arial" color="#008040" size="2">266%
in two days </font><font lang="0" face="Arial" color="#008040" size="3">
</font></b></p>
<p align="left"><b><font face="Arial" color="#008040">These types of gains
happen every day in the world of Pink sheets! Lets look at today's
featured company: Bioelectronics Corp.</font><font lang="0" face="Arial" color="#000000" size="3"><br>
<br>
</font><font lang="0" face="Arial" color="#000000" size="2">Bioelectronics
Corp: </font><font lang="0" face="Arial" color="#800000" size="2">BIEL
</font><font lang="0" face="Arial" color="#000000" size="2"><br>
</font><font lang="0" face="Arial" color="#008040" size="2">Current-Price:
$0.80 <br>
</font><font lang="0" face="Arial" color="#000000" size="2"> <br>
</font></b><font lang="0" face="Arial" color="#000000" size="3"><br>
</font><font lang="0" face="Arial" color="#000000" size="2">Reasons to buy
</font><b><font lang="0" face="Arial" color="#000000" size="2">BIEL.PK : </font></b><font lang="0" face="Arial" color="#000000" size="2">BIEL
(Bioelectronics Corporation) is taking proven medical technologies and
making them available to more people in new convenient, cost-effective
dermal patches. By applying advanced microelectronic technology,
Bioelectronics is dramatically reducing the size and the cost of some
well-establ<br>
<br>
<b>BIEL</b> first FDA cleared product, ACTIPATCH (TM) therapy is a dermal
patch with an embedded microchip that delivers weeks of continuous pulsed
electromagnetic energy. ActiPatch therapy is the miniaturized
equivalent of the large pulsed electromagnetic energy machines prescribed by
physicians for decades to reduce swelling, relieve pain and enhance the
healing of surgical incisions, accidental wounds, sprains, strains and
chronic wounds (bedsores). ActiPatch's size, portability, ease of use
and relatively low price overcomes the obstacles to use associated with the
large, expensive, stationary machines. The introduction of ActiPatch
provides an immediate therapeutic alternative for the 200 million surgical
and non-surgical soft tissue injuries across the U.S. annually.
BioElectronics has launched it's ActiPatch product line in cooperative
distribution relationships with several well-established medical device
companies in various medical market segments.<br>
</font></p>
<p align="left"><font lang="0" face="Arial" color="#000000" size="2"><b>New
Products and Additional Applications: BIEL </b>and leading pharmaceutical
and device manufacturers and conducting new clinical trials. These
trials include: Abdominoplasty -- pain; Face and Forehead Lifts -- pain and
edema, Facial Fat Injections -- pain and edema; Heel -- pain and healing;
Oral Surgery -- pain; Swelling and accelerated healing; and Abdominal
Surgery -- pain and accelerated healing. Successful results in these
trials will be published and used to secure additional FDA approved
indications of use. </font></p>
<p align="left"><font face="Arial" size="2"><b>BIEL </b>is developing
products for the treatment of chronic pain, arthritis, inflammatory skin
conditions, and chronic wounds.</font><font lang="0" face="Arial" color="#000000" size="3"><br>
</font><font lang="0" face="Arial" color="#000000" size="1"><br>
<br>
</p>
<div id="messageBody0">
Information within this email contains "forward looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements that
express or involve discussions with respect to predictions, goals,
expectations, beliefs, plans, projections, objectives, assumptions or
future events or performance are not statements of historical fact and
may be "forward looking statements." <br>
<br>
Forward looking statements are based on expectations, estimates and
projections at the time the statements are made that involve a number of
risks and uncertainties which could cause actual results or events to
differ materially from those presently anticipated. Forward looking
statements in this action may be identified through the use of words
such as: "projects", "foresee", "expects", "estimates," "believes,"
"understands" "will", "anticipates," or that by statements indicating
certain actions "may," "could," or "might" occur. All information
provided within this email pertaining to investing, stocks, securities
must be understood as information provided and not investment advice. WE
advise all readers and subscribers to seek advice from a registered
professional securities representative before deciding to trade in
stocks featured within this email. None of the material within this
report shall be construed as any kind of investment advice. GS Research
and/or its officers and employees have been compensated $10,000.00 cash
by a third party for work involved in the preparation and production of
this report<p>In compliance with Section 17(b), we disclose the holding
of independently purchased shares of the company mentioned prior to the
publication of this report.. Be aware of an inherent conflict of
interest resulting from such holdings due to our intent to profit from
the liquidation of these shares. Shares may be sold at any time, even
after positive statements have been made regarding the above company.
Short term trading targets are only guesses on our part. Keep in mind
that when trading small stocks like the company above there is a chance
you will lose every penny you invest. Furthermore there have been times
in the past when the Company itself tells lies, gives false information
and puts out false news. This email is for entertainment purposes only.
This is not investment advice. We suggest you check with an investment
professional before investing any stocks or mutual funds.<br>
</div>
<meta http-equiv="pragma" content="no-cache">
<meta http-equiv="cache-control" content="no-cache">
<meta http-equiv="expires" content="Sun, 21 Mar 1999 06:05:29 GMT">
<SCRIPT language=javascript>
if(top.MLRead)
top.MLRead._messageLoaded();
</SCRIPT>
<p> </font></div>
</body>
</html>